You are here: Industry Insights > cardiomyopathy

News List

Teen, Parent Response Explored for Cardiomyopathy Genetic Tests drugs
July 14, 2021
Parents with unaffected children and positive predictive cardiomyopathy genetic testing results are more likely to experience negative emotions about the results, but they have better family functioning scores, according to a study published online.
Pfizer receives CHMP recommendation for rare cardiomyopathy drug pharmaceutical-technology
December 17, 2019
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the authorisation of Pfizer’s Vyndaqel (tafamidis) ...
Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospective, randomized study in people with chronic Chagas cardiomyopathy worldpharmanews
March 19, 2019
At the Annual Meeting of the Global Chagas Disease Coalition in Barcelona, Spain, Novartis announced that it is joining the Coalition as a member contributor.
CRISPR-based heart test pinpoints genetic risk for severe cardiomyopathy fiercebiotech
December 27, 2018
Severe hypertrophic cardiomyopathy, a dangerous disorder that causes an abnormal thickening of the heart walls, can run in families—and it’s often associated with a variant in the gene TNNT2.....
Pfizer eyes ATTR cardiomyopathy filing for tafamidis after acing phase 3 trial fiercebiotech
August 28, 2018
Analysts suggest the drug could reach the market in 2019
Pfizer receives FDA Fast Track designation for tafamidis for transthyretin cardiomyopathy worldpharmanews
June 07, 2017
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to tafamidis...